,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['paradigm', 'breast', 'enhertu', 'astrazeneca']
asco: astrazeneca's enhertu is poised to change the breast cancer paradigm #pharmascrip
Scrip goes beyond the headlines to deliver insight & analysis on  drug discovery, development and product life cycle value chain.

Join us, find our latest job: